MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impedance Doesn’t Change with Levodopa Treatment

A.Y Yilmaz, C. Akbostanci, A. Savas (Ankara, Turkey)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1391

Keywords: Deep brain stimulation (DBS), Dopamine

Category: Surgical Therapy: Parkinson's Disease

Objective: We aimed to evaluate the impedance of patients on their best ON/worst OFFs with levodopa, assuming that the level of dopamine at electrode’s vicinity is high or low, respectively.

Background: Impedance (effective resistance to alternating current) is a variable parameter. In vivo studies showed that the presence of dopamine decreases impedance of DBS electrode.

Method: 24 patient with PD treated with STN DBS consented to join. Medical treatment and DBS configuration were not changed at least for three months. Impedance is assessed after withdrawal of dopaminergic medication for at least 12 hours and after taking levodopa when patients tell that are at their best ON (approximately one hour later).

Results: There was no significant difference between therapy impedances of ON medication and medication-free groups [table 1] . Also 158 of 160 contact electrode impedances didn’t differ significantly.

Conclusion: Levodopa therapy doesn’t effect either therapy and electrode impedance. This means that impedance can be measured regardless of whether the patient is drug-ON or OFF state, and presumed presence of high levels of dopamine does not effect impedance values in humans.

impedance table

To cite this abstract in AMA style:

A.Y Yilmaz, C. Akbostanci, A. Savas. Impedance Doesn’t Change with Levodopa Treatment [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/impedance-doesnt-change-with-levodopa-treatment/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/impedance-doesnt-change-with-levodopa-treatment/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley